Cosmo Pharmaceuticals NV
LSE:0RGI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Cosmo Pharmaceuticals NV (0RGI) under the Base Case is CHF per share.
Compared with the current market price of 53.4 CHF, the stock appears .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Cosmo Pharmaceuticals Does
Cosmo Pharmaceuticals is a specialty drug company focused on digestive health and endoscopy. It develops medicines and medical products used to treat gastrointestinal conditions and to help doctors inspect and treat the colon and other parts of the digestive tract. Its products are aimed mainly at hospitals, gastroenterologists, and sometimes pharmacies, depending on the product and market.
- Headquarters
- Ireland IE
- Employees
- 325
- IPO date
- May 18, 2016
Balance Sheet
Continue 0RGI Research
Decided on Cosmo Pharmaceuticals? Get an email when 0RGI reaches the price you’d buy at. Free with an account.
Other Cosmo Pharmaceuticals listings
What is the Intrinsic Value of one 0RGI stock?
The intrinsic value for
Cosmo Pharmaceuticals NV (0RGI) under the Base Case is CHF.
Is 0RGI stock undervalued or overvalued?
Compared with the current market price of 53.4 CHF, the stock appears .